Product image of Akynzeo (Palonosetron, Fosnetupitant) supplied by GNH India

Akynzeo

Active Ingredient:
Palonosetron, Fosnetupitant
Origin:
EU

Akynzeo (Palonosetron, Fosnetupitant)

Akynzeo is a combination medication used to prevent nausea and vomiting caused by chemotherapy. It contains palonosetron and fosnetupitant, offering a dual-action approach for effective relief.

Manufacturer / TM Owner

Helsinn Birex Pharmaceuticals Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Akynzeo is primarily used to prevent nausea and vomiting in patients undergoing chemotherapy. This medication targets both acute and delayed nausea, providing comprehensive support during cancer treatment. Patients often seek Akynzeo for its ability to manage chemotherapy-induced nausea and vomiting effectively.

Side Effects

  • Akynzeo works by blocking specific receptors in the body that trigger nausea and vomiting. This dual-action formula helps to alleviate symptoms both immediately and over an extended period, offering relief to patients undergoing chemotherapy.

Precautions & Warnings

  • Akynzeo should be used under medical supervision, especially for patients with a history of heart conditions or electrolyte imbalances. It is important to follow the prescribed guidelines and inform healthcare providers about any existing medical conditions or medications being taken.

Avoid Interactions

  • Akynzeo may interact with other medications, particularly those that affect heart rhythm or are metabolized by the liver. It is advisable to consult a healthcare provider before combining Akynzeo with other treatments, including herbal supplements and over-the-counter drugs.

Frequently Asked Questions

Akynzeo is used to prevent nausea and vomiting caused by chemotherapy in cancer patients.

Akynzeo combines palonosetron and fosnetupitant to block receptors that trigger nausea and vomiting, providing both immediate and prolonged relief.

Akynzeo may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Common side effects of Akynzeo may include headache, fatigue, and constipation. Patients should report any severe or persistent symptoms to their healthcare provider.

Akynzeo is generally used for patients undergoing chemotherapy, but it should be used under medical supervision, especially for those with heart conditions or electrolyte imbalances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Palonosetron, Fosnetupitant

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT